Genelux Corp (NAS:GNLX)
$ 2.725 +0.060 (+2.26%) Market Cap: 122.19 Mil Enterprise Value: 98.25 Mil PE Ratio: 0 PB Ratio: 5.33 GF Score: 30/100

Genelux Corp at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 07:30 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GNLX.OQ - Genelux Corp
Genelux Corp at TD Cowen Healthcare Conference
Mar 02, 2026 / 07:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi everybody. Good afternoon. Welcome to the forty-sixth annual TD Cowan Healthcare Conference. I'm Nathan Feinstein from TD Cowan, and I'm here to introduce the, Gene Lux executive team to present to us. Here's, Thomas Zinri, the CEO, and Matt Pulisic, the CFO. Without further ado.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Great.

Thank you very much. Appreciate the opportunity to present the Gen Lux, story today.

So at Genolux, our mission.

Is to address some of the most significant problems in oncology today.

And we want to do it in a way
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot